Login
$AORT
$18.47 +$0.00 (0.0%) After hours

Company Executives

Management Team

From the 10-K annual report
Officer Age In this role Joined 2025 pay Source
J. Patrick Mackin Also a director
Chairman, President, and Chief Executive Officer
59 Not stated Not stated $6,883,108
James P Mackin
President & CEO
Title from the Form 4 dated Aug 19, 2026
Not stated Not stated Not stated Not reported
Lance A. Berry
Executive Vice President, Chief Operating Officer, Chief Financial Officer and Treasurer
53 Since 2025
1 year
Not stated $2,977,091
Jason Asper
Senior Vice President and Chief Strategy and Digital Officer
51 Since 2025
1 year
Not stated Not reported
John E. Davis
Chief Commercial Officer
61 Since 2024
2 years
Not stated $1,958,047
Jean F. Holloway
Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary
68 Not stated Not stated $1,909,597
Amy D. Horton
Vice President, Chief Accounting Officer
55 Since 2016
10 years
1998 Not reported
Marshall S. Stanton
Senior Vice President, Clinical Research and Chief Medical Officer
69 Since 2021
5 years
Not stated $1,660,393
Andrew M. Green
Senior Vice President, Regulatory and Quality
57 Since 2025
1 year
Not stated Not reported
Matthew A. Getz
Vice President, Human Resources
57 Since 2019
7 years
Not stated Not reported
Rochelle L. Maney
Vice President, Quality Systems and Tissue Quality
49 Not stated Not stated Not reported
Robert C. Thomson
Vice President, Research and Development
56 Since 2023
3 years
Not stated Not reported
Florian Tyrs
Vice President, Global Operations
44 Since 2023
3 years
2006 Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
9
serving now
Independent
8 of 8
stated in the proxy; 1 not stated
Average tenure
12.0 years
from year joined
CEO also chairs the board
Yes
J. Patrick Mackin
Director On board Independent Committees 2025 pay Source
J. Patrick Mackin
2014
12 years
Not stated None stated Paid as CEO
Jeffrey H. Burbank
2017
9 years
Independent
Audit Committee Corporate Governance Committee · Chair
$295,010
Thomas F. Ackerman
2003
23 years
Independent
Audit Committee · Chair Innovation and Healthcare Compliance Committee
$260,010
Daniel J. Bevevino
2003
23 years
Independent
Audit Committee Compensation Committee · Chair
$265,010
Marna P. Borgstrom
2018
8 years
Independent
Corporate Governance Committee Innovation and Healthcare Compliance Committee · Chair
$250,010
James W. Bullock
2016
10 years
Independent
Compensation Committee Innovation and Healthcare Compliance Committee
$247,510
Elizabeth A. Hoff
2022
4 years
Independent
Corporate Governance Committee Innovation and Healthcare Compliance Committee
$245,010
Jon W. Salveson
2012
14 years
Independent
Corporate Governance Committee Innovation and Healthcare Compliance Committee
$245,010
Anthony B. Semedo
2021
5 years
Independent
Compensation Committee Innovation and Healthcare Compliance Committee
$247,510

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 1, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support